Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Geron presents encouraging data on HIV drug candidate
The data confirm and extend earlier findings that TAT0002 enhances the function of key immune cells from HIV/AIDS donors. The results show that TAT0002 stimulates RANTES, MIP1-alpha and
The data confirm and extend earlier findings that TAT0002 enhances the function of key immune cells from HIV/AIDS donors. The results show that TAT0002 stimulates RANTES, MIP1-alpha and
Details of the newly submitted application have not been made public, but it is widely thought that the company may be seeking approval for the drug to be
La Jolla Institute for Allergy & Immunology scientist Dr Mitchell Kronenberg and an international team of scientists have identified that Borrelia burgdorferi, the bacteria that causes Lyme disease,
The Penn researchers found that IL-27 inhibits the immune system cells responsible for an array of inflammatory-related diseases, including encephalitis, arthritis, Crohn’s disease, and lupus. Their findings, which
Through a GBP7 million cash investment, Rexam, the world’s largest beverage can maker, will acquire a majority stake in a new drinks can plant, the first of its
The test will be based on the Primer and Probe Set and protocols used in a test developed by the Centers for Disease Control and Prevention (CDC) that
All of the biotechnology medicines and vaccines are now in clinical trials or awaiting approval from the FDA. They include 210 medicines to treat cancer, 50 to treat
The first new hospital buildings, in which up to half of the beds will be in single rooms, are expected to open from 2010. The go-ahead for the
Black cohosh, also known as Actaea racemosa or Cimicifuga racemosa, is a herbal remedy that is often used to relieve menopausal and premenstrual symptoms. Common names for it
In its letter, the FDA has requested submission of additional data to support the clinical evidence presented by Lilly in its new drug application. Lilly plans to meet